Loading...
XJPX
4694
Market cap957mUSD
Dec 05, Last price  
3,835.00JPY
1D
0.52%
1Q
3.93%
Jan 2017
37.65%
IPO
95.66%
Name

BML Inc

Chart & Performance

D1W1MN
XJPX:4694 chart
P/E
23.75
P/S
1.04
EPS
161.49
Div Yield, %
2.35%
Shrs. gr., 5y
-1.56%
Rev. gr., 5y
3.47%
Revenues
143.19b
+3.79%
70,712,565,00071,834,307,00072,832,496,00077,198,713,00079,259,997,00080,762,000,00092,201,000,00094,608,000,00099,047,000,000104,404,000,000109,024,000,000111,243,000,000113,502,000,000117,129,000,000120,732,000,000138,571,000,000186,067,000,000159,462,000,000137,964,000,000143,191,000,000
Net income
6.26b
+3.81%
1,972,454,0002,085,793,0002,373,831,0003,075,220,0003,550,233,0003,594,000,0002,392,000,0003,708,000,0004,990,000,0003,874,000,0005,424,000,0005,948,000,0005,988,000,0006,646,000,0006,375,000,00013,711,000,00033,741,000,00015,578,000,0006,034,000,0006,264,000,000
CFO
15.81b
+9.44%
7,422,525,0005,320,690,0006,397,100,0007,717,551,0009,388,279,0008,683,000,0008,092,000,0009,792,000,00010,931,000,00011,495,000,00011,978,000,00011,307,000,00012,079,000,00012,507,000,00012,771,000,00019,574,000,00045,603,000,00011,742,000,00014,446,000,00015,809,000,000
Dividend
Mar 30, 202660 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
IPO date
Apr 25, 2001
Employees
4,415
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT